The EU AI Act: Rethinking Translation Compliance in Life Sciences
Does the EU AI Act impact how medical device, biotech, and pharmaceutical companies translate their content? Yes, the EU AI Act directly impacts localization and translation pipelines for life sciences companies operating in Europe. When artificial intelligence is used to translate critical healthcare data—such as clinical trial protocols or medical device Instructions for Use (IFUs)—the […]
The EU AI Act: Rethinking Translation Compliance in Life Sciences Read More »









